Showing results (1-10 of 59) with videos related to
Sort By:
Pageof 6
Fertility and Sterility|October 15, 2018
Infertility: a marker of future health risk in women?Suneeta SenapatiClinical Obstetrics and Gynecology|October 28, 2011
Managing endometriosis-associated infertilitySuneeta Senapati, Kurt BarnhartBlood|July 12, 2019
Fertility preservation in patients with hematologic malignancies and recipients of hematopoietic cell transplantsAlison Wakoff Loren, Suneeta SenapatiFertility and Sterility|January 8, 2013
Biomarkers for ectopic pregnancy and pregnancy of unknown locationSuneeta Senapati, Kurt T BarnhartFertility and Sterility|December 3, 2014
Use of gonadotropin-releasing hormone agonist trigger during in vitro fertilization is associated with similar endocrine profiles and oocyte measures in women with and without polycystic ovary syndromeKathleen E O'Neill, Suneeta Senapati, Anuja DokrasJournal of Assisted Reproduction and Genetics|June 29, 2017
Medical and elective fertility preservation: impact of removal of the experimental label from oocyte cryopreservationSamantha B Schon, Maren Shapiro, Clarisa Gracia, et al.Fertility and Sterility|April 10, 2016
Impact of endometriosis on in vitro fertilization outcomes: an evaluation of the Society for Assisted Reproductive Technologies DatabaseSuneeta Senapati, Mary D Sammel, Christopher Morse, et al.F&S Reports|May 9, 2022
Impact of the COVID-19 pandemic on the perception of planned oocyte cryopreservation in the United StatesAlexandra Huttler, Nathanael Koelper, Monica Mainigi, et al.Fertility and Sterility|April 27, 2025
Special considerations in assisted reproductive technology for patients with hematologic diseaseJoshua A Ewy, Suneeta Senapati, Nadia D Ali, et al.Journal of Assisted Reproduction and Genetics|June 29, 2016
GnRH agonist with low-dose hCG (dual trigger) is associated with higher risk of severe ovarian hyperstimulation syndrome compared to GnRH agonist aloneKathleen E O'Neill, Suneeta Senapati, Ivy Maina, et al.Pageof 6